| Product Name |
Etravirine |
| Product Category | Pharmaceutical API's, Intermediates |
| Sub-Category | Pharmaceutical Standards, Enzyme Inhibitors, Fine Chemicals, Non Nucleoside Reverse Transcriptase Inhibitors |
| CAS No | 269055-15-4 |
| Catalog Number | GS.42.ETN.00 |
| Chemical Name/Synonyms | 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-benzonitrile ; 4-((6-Amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile ; 4-[6-Amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile |
| Molecular Weight | 435.28 |
| Molecular Formula | C20H15BrN6O |
| Purity | NLT 98% |
| Appearance | White to Off-White Solid |
| Solubility | DMSO, Methanol |
| Applications | Etraverine is used clinically for the treatment of human immunodeficiency virus type 1 infection. It is an antiretroviral agent more specifically classified as a Non-Nucleoside Reverse Transcriptase Inhibitor. |
| Inventory Status | QC Pending |